Experience in transumbilical endoscopic surgery diagnosis for 3 cases of pseudomyxoma peritonei.
- Author:
Li TIAN
1
;
Anliu TANG
1
;
Fen LIU
1
;
Shourong SHEN
1
;
Xiaoyan WANG
1
Author Information
1. Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
- Publication Type:Case Reports
- MeSH:
Antineoplastic Agents;
therapeutic use;
Ascites;
etiology;
Blood Loss, Surgical;
Cicatrix;
prevention & control;
Costs and Cost Analysis;
Humans;
Hyperthermia, Induced;
Laparoscopy;
adverse effects;
economics;
methods;
Length of Stay;
Operative Time;
Peritoneal Neoplasms;
Pseudomyxoma Peritonei;
diagnosis;
mortality;
therapy;
Retrospective Studies;
Treatment Outcome
- From:
Journal of Central South University(Medical Sciences)
2016;41(11):1241-1244
- CountryChina
- Language:Chinese
-
Abstract:
Three patients of pseudomyxoma peritonei who were diagnozed by transumbilical endoscopic surgery (TUES) were reviewed retrospectively from September 2014 to November 2014. Three cases of ascites patients underwent TUES were diagnozed as pseudomyxoma peritonei. All operations were successful. No open surgery or laparoscopic surgery was required. The mean operative time was (45±16) min; the mean intraoperative blood loss was 510 mL; the mean hospital stay time was 3 days. During the follow up of 911 months, no obvious scar was observed. Cosmetic results appear to be excellent. All patients were treated with intraperitoneal hyperthermia and chemotherapy. The survival rate was 100%. As a novel scarless endoscopic invasive abdominal surgery, TUES has high clinical value with the advantages such as small trauma, no scars, small risk and low cost in the diagnosis of unexplained ascites.
